NCT01818661View on ClinicalTrials.gov

Longitudinal Multi-Modality Imaging in Progressive Apraxia of Speech

PHASE4RecruitingINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

July 1, 2018

Primary Completion Date

June 30, 2028

Study Completion Date

June 30, 2028

Conditions
PPANon-fluent AphasiaApraxia of SpeechPrimary Progressive Non-fluent AphasiaPrimary Progressive Aphasia
Interventions
DRUG

AV-1451

This is used to assess Tau burden in the brain.

Trial Locations (1)

55905

RECRUITING

Mayo Clinic, Rochester

Sponsors

Lead Sponsor

Mayo Clinic
All Listed Sponsors
collaborator

National Institute on Deafness and Other Communication Disorders (NIDCD)

NIH

lead

Mayo Clinic

OTHER

NCT01818661 - Longitudinal Multi-Modality Imaging in Progressive Apraxia of Speech | Biotech Hunter | Biotech Hunter